CRISPR/Cas9 Technology in Antimicrobial Resistance and Cardiovascular Therapeutics: Current Advances and Future Perspectives
International Journal for Research Trends and Innovation · 2026 · 11 (6)
DOI: 10.56975/ijrti.v11i6.213428 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal for Research Trends and Innovation, 2026. Verfasst von Sri devi M und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
M, S. D., B, B., & C.Philip, D. (2026). CRISPR/Cas9 Technology in Antimicrobial Resistance and Cardiovascular Therapeutics: Current Advances and Future Perspectives. International Journal for Research Trends and Innovation, 11(6). https://doi.org/10.56975/ijrti.v11i6.213428
Vancouver
M SD, B B, C.Philip D. CRISPR/Cas9 Technology in Antimicrobial Resistance and Cardiovascular Therapeutics: Current Advances and Future Perspectives. International Journal for Research Trends and Innovation. 2026;11(6). doi:10.56975/ijrti.v11i6.213428
BibTeX
@article{M2026,
author = {M, Sri devi and B, Bharathi and C.Philip, Deepa},
title = {CRISPR/Cas9 Technology in Antimicrobial Resistance and Cardiovascular Therapeutics: Current Advances and Future Perspectives},
journal = {International Journal for Research Trends and Innovation},
year = {2026},
volume = {11},
number = {6},
doi = {10.56975/ijrti.v11i6.213428}
}
EUVIMED